Primary Results of the phase II CheckRad-CD8 Trial: First-Line Treatment of locally advanced Head and Neck Tumors with double Checkpoint Blockade and Radiotherapy dependent on intratumoral CD8+T-Cell Infiltration

Hecht M, Eckstein M, Rutzner S, Von Der Gruen J, Illmer T, Klautke G, Laban S, Hautmann M, Brunner T, Tamaskovics B, Hinke A, Frey B, Semrau S, Hartmann A, Balermpas P, Budach W, Gaipl U, Iro H, Gostian AO, Fietkau R (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Strahlentherapie und Onkologie Urban & Vogel

Publisher: SPRINGER HEIDELBERG

City/Town: HEIDELBERG

Pages Range: S9-S10

Conference Proceedings Title: STRAHLENTHERAPIE UND ONKOLOGIE

DOI: 10.1200/jco.2021.39.15_suppl.6007

Authors with CRIS profile

Markus Hecht Department of Radiation Oncology Markus Eckstein Institute of Pathology Sandra Rutzner Department of Radiation Oncology Benjamin Frey Department of Radiation Oncology Sabine Semrau Medizinische Fakultät Arndt Hartmann Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Udo Gaipl Department of Radiation Oncology Heinrich Iro Lehrstuhl für Hals-, Nasen- und Ohrenheilkunde Antoniu-Oreste Gostian Department of Otorhinolaryngology – Head and Neck Surgery Rainer Fietkau Lehrstuhl für Strahlentherapie

Involved external institutions

Otto-von-Guericke-Universität Magdeburg DE Germany (DE) Universität Ulm DE Germany (DE) Universität Regensburg DE Germany (DE) Goethe-Universität Frankfurt am Main DE Germany (DE) Heinrich-Heine-Universität Düsseldorf DE Germany (DE) Klinikum Chemnitz DE Germany (DE)

How to cite

APA:

Hecht, M., Eckstein, M., Rutzner, S., Von Der Gruen, J., Illmer, T., Klautke, G.,... Fietkau, R. (2021). Primary Results of the phase II CheckRad-CD8 Trial: First-Line Treatment of locally advanced Head and Neck Tumors with double Checkpoint Blockade and Radiotherapy dependent on intratumoral CD8+T-Cell Infiltration. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S9-S10). HEIDELBERG: SPRINGER HEIDELBERG.

MLA:

Hecht, Markus, et al. "Primary Results of the phase II CheckRad-CD8 Trial: First-Line Treatment of locally advanced Head and Neck Tumors with double Checkpoint Blockade and Radiotherapy dependent on intratumoral CD8+T-Cell Infiltration." Proceedings of the STRAHLENTHERAPIE UND ONKOLOGIE HEIDELBERG: SPRINGER HEIDELBERG, 2021. S9-S10.

BibTeX: Download